Alpha-Mannosidosis

Drug Name: Lamzede Indications: To treat non-central nervous system manifestations of alpha-mannosidosis. Active Ingredient: Velmanase alfa-tycv Company: Chiesi Farmaceutici Approval Date: 2/16/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761278s000lbl.pdf